Physician
Rheumatology Services Medical Group
Rheumatology Services Medical Group was paid $1.42M by Medicaid between Jan 2018 and Nov 2024, across 11 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 40% of everything it billed.
33Billing provider infoRHEUMATOLOGY SERVICES MEDICAL GROUP
BAKERSFIELD, CA 93312
BAKERSFIELD, CA 93312
33aNPI1265783948assigned 09/21/2012
33bProvider typeRheumatology Physician
28Total paid$1.42M
24GClaims15,103
24DCodes billed11
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Rheumatology Physician providers in California
Rank by total paid#16 of 147
Median peer was paid$43K
This provider vs. median33×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,097 | $127K | |
| 2019 | 1,515 | $206K | |
| 2020 | 1,976 | $159K | |
| 2021 | 2,320 | $200K | |
| 2022 | 2,310 | $303K | |
| 2023 | 3,337 | $233K | |
| 2024incomplete | 2,548 | $196K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 40% | 8,064 | 7,977 | $563K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22% | 238 | 214 | $306K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 19% | 243 | 141 | $265K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.2% | 1,594 | 1,558 | $88K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.5% | 633 | 632 | $79K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5.4% | 2,181 | 2,033 | $77K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 1,168 | 1,067 | $27K |
| 96415 | <1% | 223 | 191 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 477 | 460 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 103 | 89 | $3K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 179 | 178 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBERRY, MARTIN (MANAGING PARTNER)